← brief for 2026-09-19 · Slowing decline

Are SGLT2 inhibitors more effective in specific subgroups of patients with chronic kidney disease (CKD)?

Article No results yet Not peer reviewed

Key takeaways

This preprint asks if SGLT2 drugs work better for certain groups of people. It notes that these drugs help people with and without diabetes. It says more research is needed for people on dialysis. It does not report new trial data.

Who did this work

Tripdatabase (Triphase (Belgium))

Source

Article · OpenAlex, CKD works · 2026-09-18
https://doi.org/10.5281/zenodo.22834956